Peripheral markers of glutamatergic dysfunction in neurological diseases: Focus on ex vivo tools

Critical Reviews in Neurobiology

Volumn 16, Issue 1-2, 2004, Pages 141-146

  Tremolizzo, Lucio ^b   Beretta, Simone ^b   Ferrarese, Carlo ^a  

^a SAN GERARDO HOSPITAL   (Italy)

^b NONE

Author keywords

CSF; Excitotoxicity; Fibroblasts; Glutamate; Neurodegenerative diseases; Peripheral markers; Plasma; Platelets; Stroke

Indexed keywords

GLUTAMIC ACID;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ALZHEIMER DISEASE; AMINO ACID BLOOD LEVEL; AMINO ACID TRANSPORT; AMYOTROPHIC LATERAL SCLEROSIS; DOWN SYNDROME; EARLY DIAGNOSIS; EX VIVO STUDY; FIBROBLAST; GENETIC PREDISPOSITION; HUMAN; INFLAMMATION; NERVE CELL NECROSIS; NEUROLOGIC DISEASE; OXIDATIVE STRESS; PARKINSON DISEASE; PATHOGENESIS; PROGNOSIS; REVIEW; STROKE; THROMBOCYTE;

BIOLOGICAL MARKERS; BLOOD PLATELETS; FIBROBLASTS; GLUTAMATES; HUMANS; NERVOUS SYSTEM DISEASES;

EID: 9744248327     PISSN: 08920915     EISSN: None     Source Type: Journal    
DOI: 10.1615/CritRevNeurobiol.v16.i12.150     Document Type: Review

References (24)

1. Ferrarese C, Beal MF, editors. Excitotoxicity in neurological Diseases: New Therapeutic Challenge. Kluwer Academic Publishers, 2003.
2. Ferrarese C, Pecora N, Frigo M, Appollonio I, Frattola L. Assessment of reliability and biological significance of glutamate levels in cerebrospinal fluid. Ann Neurol 1993; 33:316-319.
3. Castillo J, Davalos A, Naveiro J, Noya M. Neuroexcitatory amino acids and their relation to infarct size and neurological deficit in ischemic stroke. Stroke 1996; 27:1060-1065.
4. Davalos A, Castillo J, Serena J, Noya M. Duration of glutamate release after acute ischaemic stroke. Stroke 1997; 28:708-710.
5. Castillo J, Davalos A, Noya M. Progression of ischaemic stroke and excitotoxic aminoacids. Lancet 1997; 349:79-83.
6. Tremolizzo L, Longoni M, Aliprandi A, et al. Platelet glutamate uptake and plasma glutamate levels in stroke patients. Ann Neurol 2001; 50 (Suppl 1):S42.
7. Mangano RM, Schwarcz R. The human platelet as a model for the glutamatergic neuron: platelet uptake of L-glutamate. J Neurochem 1981; 36:1067-1076.
8. Zoia C, Cogliati T, Tagliabue E, et al. Glutamate transporters in platelets: EAAT1 decrease in aging and in Alzheimer disease. Neurobiol Aging 2004; 25:149-157.
9. Joseph R, Tsering C, Grunfeld S, Welch KM. Platelet secretory products may contribute to neuronal injury. Stroke 1991; 22:1448-1451.
10. Ferrarese C, Aliprandi A, Tremolizzo L, et al. Increased glutamate in CSF and plasma of patients with HIV dementia. Neurology 2001; 57:671-675.
11. Rothstein JD, Kuncl RW, Chaudhry V, et al. Excitatory amino acids in amyotrophic lateral sclerosis: an update. Ann Neurol 1991; 30:224-225.
12. Camu W, Billiard M, Baldy-Moulinier M. Fasting plasma and CSF amino acid levels in amyotrophic lateral sclerosis: a subtype analysis. Acta Neurol Scand 1993; 88:51-55.
13. Spreux-Varoquaux O, Bensimon G, Lacombez L, et al. Glutamate levels in cerebrospinal fluid in amyotrophic lateral sclerosis: a reappraisal using a new HPLC method with coulometric detection in a large cohort of patients. J Neurol Sci 2001; 193:73-78.
14. Plaitakis A, Caroscio JT. Abnormal glutamate metabolism in amyotrophic lateral sclerosis. Ann Neurol 1987; 22:575-579.
15. Rothstein JD, Martin LJ, Kuncl RW. Decreased glutamate transport by the brain and spinal cord in amyotrophic lateral sclerosis. N Engl J Med 1992; 326:1464-1468.
16. Ferrarese C, Sala G, Riva R, et al. Decreased platelet glutamate uptake in patients with amyotrophic lateral sclerosis. Neurology 2001; 56:270-272.
17. Cooper B, Chebib M, Shen J, et al. Structural selectivity and molecular nature of L-glutamate transport in cultured human fibroblasts. Arch Biochem Biophys 1998; 353:356-364.
18. Mangano RM, Schwarcz R. Platelet glutamate and aspartate uptake in Huntington's disease. J Neurochem 1981; 37:1072-1074.
19. Ferrarese C, Begni B, Canevari C, et al. Glutamate uptake is decreased in platelets from Alzheimer's disease patients. Ann Neurol 2000; 47:641-643.
20. Begni B, Brighina L, Fumagalli L, et al. Altered glutamate uptake in peripheral tissues from Down's sindrome patients. Neurosci Lett 2003; 343:73-76.
21. Ferrarese C, Zoia C, Pecora N, et al. Reduced platelet glutamate uptake in Parkinsons disease. J Neural Transm 1999; 106:685-692.
22. Sorg O, Horn TF, Yu N, Gruol DL, Bloom FE. Inhibition of astrocyte glutamate uptake by reactive oxygen species: role of antioxidant enzymes. Mol Med 1997; 3:431-440.
23. Lovell MA, Xie C, Markesbery WR. Acrolein, a product of lipid peroxidation, inhibits glucose and glutamate uptake in primary neuronal cultures. Free Radic Biol Med 2000; 29:714-720.
24. Ye ZC, Sontheimer H. Cytokine modulation of glial glutamate uptake: a possible involvement of nitric oxide. Neuroreport 1996; 7:2181-2185.